Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTTTAATCCTCATTGGAAAACACCATCTTTTCCTAATATACATTTACACCAAGACATTATCAAAAAATGTGAACAGTTTGTAGGCCCACTCACAGTTAA| |TGAGAAAAGAAGATTGCAATTGATTATGCCTGCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGGGTATTAAACCTTATTATCCAGAA
End
3353560/3353562 (Hg38)
Nearest miRNA
hsa-mir-1227/Upstream/722769; hsa-let-7e/Downstream/607852;
Upstream sequence
gacagcataacaccccctctgccatatctaatcgtaggtcaatgggcaagcaaagcatcatacatccatacagttcaatccccatccccagtaaaagaat
Downstream sequence
gcacagtcatacacagaatcacatgaacaaatctcagataatgatgccgagtgaaagacaccggacactaaGAATGCTGCTGGCCCcagctatgctcatc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.